Our clinical center is designed for the Phase 1 (first-in-man) clinical studies which is an asset for bioequivalence studies. The procedures used allow the full control of the clinical operations and to experiment the study protocol as written and to record the data clearly. Our personnel is qualified, multilingual, which complies with the bioethic standards when interacting with multiethnic population.